Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 110   

Articles published

JNJ 97.44 -0.02 (-0.02%)
price chart
Has Johnson & Johnson's Stock Peaked?
Johnson & Johnson's stock has come down slightly from its peak value and has been more or less stable for a while in absence of any meaningful triggers.
Now is not the time for Johnson & Johnson
Johnson & Johnson has been the poster child for dividend-paying growth stocks for many years. For the buy-and-hold investor, it is a great company to own because of its long-term outperformance of the S&P 500 benchmark and its compound annual ...
Technical Report on Johnson & Johnson (NYSE:JNJ)  Markets Wired
Only Nine Dow Components With Recent Insider Buying, JNJ is One of Them  Forbes
Better Dividend Stock: AbbVie or Johnson & Johnson?
As we all have to make tough investing choices, though, it can be difficult to decide which dividend payers to buy, especially among top dogs such as AbbVie (NYSE: ABBV ) and Johnson & Johnson (NYSE: JNJ ) . These two healthcare companies have a ...
Interesting September Stock Options for Johnson & Johnson
So unless Johnson & Johnson sees its shares fall 5.6% and the contract is exercised (resulting in a cost basis of $94.09 per share before broker commissions, subtracting the 91 cents from $95), the only upside to the put seller is from collecting that ...
Johnson & Johnson Has a Dirty Secret About Microbeads
Instead of moving to safe, natural alternatives, Johnson & Johnson wants to replace plastic microbeads with more plastic.
Will Incoming Threats Sink Johnson & Johnson?
Johnson & Johnson (NYSE:JNJ) is a massive cruise ship in the pharmaceutical industry, but there are plenty of fast-moving sharks skimming around its waters.
Johnson & Johnson (JNJ): Strong Drug Pipeline May Reap Benefits  Bidness ETC
How High Could Johnson & Johnson's Dividend Go?
For retirees, income investors, and those investors with a risk-averse investing style, chances are that healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is a company you've considered, or rely on in your own investment or retirement portfolio.
Is Johnson & Johnson's Future on the Fast Track?  Motley Fool
Johnson & Johnson And The Supplemental Income Approach (JNJ)  Seeking Alpha
Johnson & Johnson Stock Rating Upgraded by Zacks (JNJ)
Johnson & Johnson logo Johnson & Johnson (NYSE:JNJ) was upgraded by Zacks from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, MarketBeat reports.
Q2 Earnings of $1.71 Expected for Johnson & Johnson (NYSE:JNJ)  Markets Daily
The Johnson & Johnson Numbers You Should Know
In the case of Johnson & Johnson (NYSE:JNJ), a behemoth blue chip known for stable dividends and deep product pipelines, there are a few key numbers that you have to keep an eye on before Q2 results are reported.
Should I Buy Johnson & Johnson? 3 Pros and 3 Cons (JNJ)
Product Mix: Johnson & Johnson essentially has two sides to its business. It sells low-price, brand-name products like band aids, soaps and other health and beauty products.